- Home
- AWH vs BRTX Comparison
AWH vs BRTX Comparison
Compare AWH & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWH
- BRTX
- Stock Information
- Founded
- AWH 1993
- BRTX 1997
- Country
- AWH United States
- BRTX United States
- Employees
- AWH N/A
- BRTX N/A
- Industry
- AWH Medical/Dental Instruments
- BRTX Managed Health Care
- Sector
- AWH Health Care
- BRTX Health Care
- Exchange
- AWH Nasdaq
- BRTX Nasdaq
- Market Cap
- AWH 11.7M
- BRTX 11.3M
- IPO Year
- AWH N/A
- BRTX N/A
- Fundamental
- Price
- AWH $0.81
- BRTX $1.43
- Analyst Decision
- AWH Buy
- BRTX Strong Buy
- Analyst Count
- AWH 2
- BRTX 1
- Target Price
- AWH $4.40
- BRTX $18.00
- AVG Volume (30 Days)
- AWH 76.2K
- BRTX 98.3K
- Earning Date
- AWH 11-14-2024
- BRTX 11-12-2024
- Dividend Yield
- AWH N/A
- BRTX N/A
- EPS Growth
- AWH N/A
- BRTX N/A
- EPS
- AWH N/A
- BRTX N/A
- Revenue
- AWH $8,963,000.00
- BRTX $377,000.00
- Revenue This Year
- AWH $11.87
- BRTX $482.76
- Revenue Next Year
- AWH $79.10
- BRTX $212.24
- P/E Ratio
- AWH N/A
- BRTX N/A
- Revenue Growth
- AWH N/A
- BRTX 189.55
- 52 Week Low
- AWH $0.67
- BRTX $1.03
- 52 Week High
- AWH $5.65
- BRTX $3.67
- Technical
- Relative Strength Index (RSI)
- AWH 50.69
- BRTX 43.98
- Support Level
- AWH $0.68
- BRTX $1.40
- Resistance Level
- AWH $0.90
- BRTX $1.53
- Average True Range (ATR)
- AWH 0.07
- BRTX 0.09
- MACD
- AWH 0.00
- BRTX 0.00
- Stochastic Oscillator
- AWH 49.09
- BRTX 57.14
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.